Follow-up Efficacy and Safety of Alitretinoin in Severe Chronic Hand Dermatitis

Hand Dermatoses Clinical Trial

Official title:
Follow up Efficacy and Safety Study of BAL4979 in the Treatment of Chronic Hand Dermatitis Refractory to Topical Treatment

Status Completed

Clinical Trial Summary

Patients who have been treated in study protocol BAP089 may have responded to treatment, and subsequently relapsed to >75% of the baseline disease severity, will be investigated for response to further treatment with alitretinoin. Also, patients who have responded with mild or moderate disease will be investigated for additional treatment effect after prolongated treatment.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00124436
Study type	Interventional
Source	Basilea Pharmaceutica
Contact
Status	Completed
Phase	Phase 3
Start date	March 2005
Completion date	February 2007

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04136574` - Hand Dermatitis in the Care and Hospital Staff
Completed	`NCT03617068` - The Effectiveness of Coconut Oil Cream as a Prevention Treatment for Occupational Hand Dermatitis Among Batik Workers	Phase 3
Completed	`NCT05471934` - Satisfaction Survey - Cicaplast Mains
Completed	`NCT00124475` - Efficacy and Safety of a Retinoid for the Treatment of Severe Chronic Hand Dermatitis	Phase 3
Completed	`NCT00890968` - Safety and Efficacy Study of Triamcinolone Acetonide DuraPeel to Treat Hand Dermatitis	Phase 2
Completed	`NCT00309621` - Safety and Efficacy of a Retinoid for the Treatment of Severe Chronic Hand Dermatitis	Phase 3